Gastrointestinal (GI) malignancies account for a large portion of
cancers worldwide. Although incidence of esophageal, gastric, and
colorectal cancers has decreased in recent years, pancreatic and
liver cancer have increased. The mainstay of GI cancer therapy is
chemoradiation and surgery. Despite significant medical
advancements, diagnosis and therapy for GI cancers remain
challenging due to tumor cell resistance to chemoradiotherapy. The
tumor's increased cell signalling due to excessive transcription
factor activation and increased stellate cell activity leads to
collagen deposition formation of a dense stroma around the tumor,
which prevents drugs from reaching the malignant cells. This leads
to tumor chemoresistance.To circumvent these difficulties, drug
therapy targeting the tumor's specific microenvironment and the
additive anticancer effect of phytochemicals can allow for more
effective treatment. This volume will be the first on the market on
the topic of phytochemicals and their effect on the tumor
microenvironment (TME). TME is an emerging area of research and the
book will be a welcome introductory addition to the field.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!